
|Articles|March 10, 2022
SEC-MALS Method for Characterizing mRNA v2
Author(s)Wyatt Technology
SEC-MALS quantifies biophysical attributes of mRNA including molar mass, percent aggregates, Rg and Rh, and how they are affected by formulation and storage conditions.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Trending on BioPharm International
1
CPHI Frankfurt 2025 Highlights Global Pharma Innovation and Manufacturing Leadership
2
AstraZeneca Lupus Treatment Support in EU Opens Door for Self-Administration Options
3
Biopharma’s Digital Hopes Versus Actual Implementation
4
Check Your Knowledge: Patient-Centric Care Through Oral Liquid Delivery
5